Clinical Trial Update: Pharmacogenetic Treatments for Alcoholism [Phase 2, Phase 3]

View source ↗

Summary

A pharmacogenetic treatment trial for alcoholism was withdrawn after Phase 2/3 development.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Alcoholism

Snippet

Sponsor: University of Virginia | Conditions: Alcoholism | Phase 2, Phase 3 | Status: WITHDRAWN